Lost Signals: New Study Shows How VAERS Buries Vaccine Harm

The U.S. Vaccine Adverse Event Reporting System (VAERS) was designed as a passive safety net, yet its structural flaws increasingly undermine its credibility. Inconsistent data entry, missing denominators, and free‑text reporting create gaps that obscure true adverse‑event frequencies. Public health agencies such as the CDC and FDA rely on timely signals to guide policy, but under‑reporting and ambiguous coding delay detection of rare but serious reactions. Understanding these limitations is essential for stakeholders who depend on accurate pharmacovigilance to protect populations and maintain confidence in immunization programs.

Jessica Rose’s forthcoming article in the Journal of Independent Medicine tackles these shortcomings with a data‑driven modernization framework. By cleaning the 2021 VAERS dataset—standardizing lot numbers, dates, and free‑text fields—she enabled a proportional reporting ratio (PRR) analysis and applied the Bradford Hill criteria to assess causality. The case study on Moderna‑induced myocarditis revealed a PRR markedly above baseline and a composite causality score of 9.76 out of 10. Crucially, an advanced AI tool automated both PRR computation and causality scoring, demonstrating how machine learning can streamline surveillance workflows.

The paper’s actionable recommendations target the CDC, FDA, and other regulators, urging standardized electronic entry forms, real‑time denominator integration, and routine AI‑assisted analytics. For businesses operating in biotech, health‑tech, or data‑science, the findings illustrate a market opportunity to supply compliant software solutions that enhance vaccine safety monitoring. Strengthening VAERS not only reduces signal loss but also safeguards public trust, a critical asset for companies dependent on vaccine uptake. Implementing Rose’s framework could transform passive reporting into a proactive, transparent system that supports rapid decision‑making across the health ecosystem.